Patients with ventricular arrhythmias: Who should be referred to an electrophysiologist?

Heart

Volumn 88, Issue 5, 2002, Pages 544-550

  Morgan, John M ^a  

^a Wessex Cardiothoracic Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BRUGADA SYNDROME; CARDIOMYOPATHY; CARDIOVERSION; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DEFIBRILLATION; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; LONG QT SYNDROME; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

EID: 0036839681     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.5.544     Document Type: Review

References (30)

1. Boriani G, Lubinski A, Capucci A, et al. A multicentre, double-blind randomised cross-over comparative study on the efficacy and safety of dofetilide versus sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J 2001;22:2180-91.
2. Camm AJ, Pratt CM, Schwartz PJ, et al. Azimilide post infarct survival evaluation (ALIVE): Azimilide does not affect mortality in post-myocardial infarction patients [abstract]. Circulation 2001;104:121.
3. Coggins DL, Lee RJ, Sweeney J, et al. Radiofrequency catheter ablation as a cure for idiopathic ventricular tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994;23:1333-41.
4. Corrado D, Basso C, Nava A, et al. Arrhythmogenic right ventricular cardiomyopathy: Current diagnostic and management strategies. Cardiol Rev 2001;9:259-65.
5. Raitt M, Dolack GL, Kudenchuk PJ, et al. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: Implications for implantable defibrillator utilisation. Circulation 1995;91:1996-2001.
6. Moss AJ, Hall WJ, Cannon DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter defibrillator implantation trial investigators. N Engl J Med 1996;335:1933-40.
7. Buxton AE, Lee KL, Fisher JD, et al. A randomised study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 1999;341:1882-90.
8. Moss AJ, Zareba W, Jackson Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
9. Roden DM, Spooner PM. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol 1999;10:1664-83.
10. Chen Q, Kirsch GE, Zhang D. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
11. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation amd sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
12. Brugada J, Brugada R, Brugada P. Right bundle branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart. Circulation 1998;97:457-60.
13. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
14. Coumel P, Fidelle J, Lucet V, et al. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: Report of four cases. Br Heart J 1978;40:28-37.
15. Priori SG, Borggrefe M, Camm AJ, on behalf of the UCARE. Role of the implantable defibrillator in patients with idiopathic ventricular fibrillation. Data from the UCARE international registry (abstract]. Eur Heart J 1995;16:94.
16. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
17. Connolly SJ, Hallsrom AP, Cappato R et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study. Eur Heart J 2000;21:2071-8.
18. Strickberger SA, Knight BP, Michaud GF, et al. Mapping and ablation of ventricular tachycardia guided by virtual electrograms using a noncontact, computerized mapping system. J Am Coll Cardiol 2000;35:414-21.
19. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647-70.
20. Brembilla-Perot B, Donetti J, de la Chaise AT, et al. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991;121:1124-31.
21. Blanck Z, Dhala A, Deshpande S, et al. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients. J Cardiovasc Electrophysiol 1993;4:253-62.
22. Cohen TJ, Chien WW, Lurie KG, et al. Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: Results and long term follow up. J Am Coll Cardiol 1991;18:1767-73.
23. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrophic cordiomyopathy: Prognostic evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiologial findings. Circulation 1992;86:730-40.
24. Kuck KH, Kunze KP, Schluter M, et al. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 1988;9:177-85.
25. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task Force on the definition and classification of cardiamyopathies. Circulation 1996;93:841-2.
26. Betts T, Roberts P, Allen S, et al. Non-contact mapping of right ventricular tachycardia from occult idiopathic right ventricular outflow tract tachycardia from occult arrhythmogenic right ventricular dysplasia. PACE 2000;23:42.
27. Betts TR, Roberts PR, Allen SA, et al. Rodiofrequency oblation of idiopathic left ventricular tachycardia at the site of earliest activation as determined by non-contact mapping. J Cardiovascular Electrophysiol 2000;11:973-9.
28. Crijns HJGM, Smeets JLRM, Rodrigues LM. Cure of interfascicular reentrant tachycardia by ablation of the anteriar fascicle of the left bundle branch. J Cardiovasc Electrophysiol 1995;6:486-92.
29. Gillette P, Yeoman M, Mullins C, et al. Sudden death after repair of tetralogy of Fallot. Electracardiographic and electraphysiologic abnormalities. Circulation 1977;56:566-70.
30. Biblo LA, Carlson MD. Transcatheter radiofrequency ablation of ventricular tachycardia following surgical correction of tetralogy of Fallot. PACE 1994;17:1556-60.